Jason Zhu

Also affiliated with UC Irvine Health, Wake Forest Baptist Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 3 papers. Top paper: “Enzalutamide versus abiraterone acetate for the treatment of men with metastatic castration-resistant prostate cancer”.

Enzalutamide versus abiraterone acetate for the treatment of men with metastatic castration-resistant prostate cancer

Expert Opinion on Pharmacotherapy(2015)10.1517/14656566.2015.995090

N/A

0.515DataRank · unranked

30 citations

Jason Zhu, Daniel J George, Andrew J Armstrong, Tian Zhang

LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-001792

N/A

0DataRank · unranked

115 citations

Matthew D. Tucker, Ramy Sedhom, Eric Schwartz, Jason Zhu, Chester Kao +12 more

Mini‐αA‐crystallin protects a client lens protein from catastrophic aggregation due to heat stress

Protein Science(2025)10.1002/pro.70199

N/A

0DataRank · unranked

3 citations

Jaewon Suk, Jason Zhu, M. Padilla, Christian F. Baca, Carter T. Butts +2 more